Yan Zhou

5.6k total citations · 1 hit paper
122 papers, 3.3k citations indexed

About

Yan Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yan Zhou has authored 122 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 30 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Yan Zhou's work include Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (10 papers). Yan Zhou is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (10 papers). Yan Zhou collaborates with scholars based in United States, China and Russia. Yan Zhou's co-authors include Nandini Dendukuri, Susan A. Shinton, Richard R. Hardy, Karthik Devarajan, Erica A. Golemis, Ilya G. Serebriiskii, Igor Astsaturov, Lynn L. Rumfelt, Margret B. Einarson and Kyoko Hayakawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yan Zhou

117 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1

2021 176 citations Alexander Beatty, Tanu Singh et al. Nature Communications profile →

Peers

Countries citing papers authored by Yan Zhou

Since Specialization

Citations

This map shows the geographic impact of Yan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Zhou more than expected).

Fields of papers citing papers by Yan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Zhou. The network helps show where Yan Zhou may publish in the future.

Co-authorship network of co-authors of Yan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Zhou. A scholar is included among the top collaborators of Yan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Zhou. Yan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-throughput and multimodal profiling of antigen-specific T cells with a droplet-based cell-cell interaction screening platform 2024 ·Biosensors and Bioelectronics ·Shiyu Wang, Yan Zhou, (unknown), (unknown), Wenjie Zhang, Yang Liu	0
2	Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer 2024 ·Cancer Discovery ·Takahiko Murayama, Jun Nakayama, (unknown), Kenichi Miyata, (unknown), Kathy Q. Cai, (unknown), (unknown), Andrey Efimov, (unknown), (unknown), Yinfei Tan, Yan Zhou, William Kim, Reo Maruyama, Kerry S. Campbell, Lü Chen, Yibin Yang, Siddharth Balachandran, Israel Cañadas	47
3	Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD 2023 ·Blood ·(unknown), Shan He, (unknown), Tien D. Bui, Yuanyuan Tian, (unknown), Yan Zhou, Xin Zhao, (unknown), (unknown), Mimi Chen, (unknown), Jozef Madžo, Jean‐Pierre J. Issa, Elizabeth O. Hexner, David L. Wiest, Ran Reshef, Hai‐Hui Xue, Yi Zhang	6
4	The expression and clinical significance of apolipoprotein C1 in cervix cancer 2023 ·European Journal of Gynaecological Oncology ·(unknown), Yan Zhou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
5	SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS) 2023 ·Clinical Cancer Research ·Sujana Movva, (unknown), Elizabeth A. Handorf, Edwin Choy, Priscilla Merriam, Douglas B. Flieder, Kathy Q. Cai, Yan Zhou, Eric D. Tetzlaff, (unknown), Emma Barker, (unknown), (unknown), Lori Rink, Margaret von Mehren, Suzanne George	14
6	A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response 2022 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Shuo Wu, Julia Ma, (unknown), Yan Zhou, Xinghong Dai, Esther Bullitt, Yanming Du, Ju‐Tao Guo, Jinhong Chang	16
7	Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1 breakdown → 2021 ·Nature Communications ·Alexander Beatty, Tanu Singh, Yulia Y. Tyurina, Vladimir A. Tyurin, Svetlana N. Samovich, Émmanuelle Nicolas, (unknown), Yan Zhou, Kathy Q. Cai, Yinfei Tan, Sebastian Doll, Marcus Conrad, Aravind Subramanian, Hülya Bayır, Valerian E. Kagan, Ulrike Rennefahrt, Jeffrey R. Peterson	176
8	A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models 2020 ·Clinical Cancer Research ·Wei Wei, (unknown), Zhihui Song, Wenming Xiao, (unknown), (unknown), Yan Zhou, Stefan K. Barta, Michael Petrus, Thomas A. Waldmann, Yibin Yang	20
9	Identification of Wee1 as a target in combination with avapritinib for gastrointestinal stromal tumor treatment 2020 ·JCI Insight ·Shuai Ye, (unknown), (unknown), Lillian R. Klug, (unknown), Martin G. Belinsky, (unknown), Margret B. Einarson, Karthik Devarajan, Yan Zhou, Samuel Litwin, Michael C. Heinrich, Ronald P. DeMatteo, Margaret von Mehren, James S. Duncan, Lori Rink	6
10	Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma 2019 ·Molecular Genetics & Genomic Medicine ·Émmanuelle Nicolas, (unknown), (unknown), Ilya G. Serebriiskii, (unknown), Pooja Ghatalia, Yan Zhou, (unknown), (unknown), Roland L. Dunbrack, Erica A. Golemis, Michael J. Hall, Mary B. Daly, Sanjeevani Arora	9
11	CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging 2018 ·Antiviral Research ·Shuo Wu, Yue Luo, (unknown), John L. Kulp, Junjun Cheng, Zhanying Hu, Qifang Xu, Yan Zhou, Guozhong Gong, Jinhong Chang, Yuhuan Li, Ju‐Tao Guo	23
12	miR-6883 Family miRNAs Target CDK4/6 to Induce G1 Phase Cell-Cycle Arrest in Colon Cancer Cells 2017 ·Cancer Research ·Amriti R. Lulla, Michael Slifker, Yan Zhou, Avital Lev, Margret B. Einarson, David T. Dicker, Wafik S. El‐Deiry	44
13	A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists 2017 ·Antiviral Research ·Bowei Liu, Liudi Tang, Xiaohui Zhang, Julia Ma, Mohit Sehgal, Junjun Cheng, Xuexiang Zhang, Yan Zhou, Yanming Du, John L. Kulp, Ju‐Tao Guo, Jinhong Chang	61
14	Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor 2016 ·Clinical Cancer Research ·(unknown), Harsh B. Pathak, Martin G. Belinsky, (unknown), Karthik Devarajan, Yan Zhou, Andrew K. Godwin, Margaret von Mehren, Lori Rink	30
15	Screening of Conditionally Reprogrammed Patient-Derived Carcinoma Cells Identifies ERCC3–MYC Interactions as a Target in Pancreatic Cancer 2016 ·Clinical Cancer Research ·(unknown), (unknown), Yan Zhou, (unknown), (unknown), (unknown), S. E. Lysenko, (unknown), Linara Gabitova, Diana Restifo, (unknown), Ilya G. Serebriiskii, John P. Hoffman, Keren Paz, Diana Behrens, Vladimir Khazak, Sandra A. Jablonski, Erica A. Golemis, Louis M. Weiner, Igor Astsaturov	47
16	Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth 2015 ·Molecular Cancer Therapeutics ·Galina Gritsina, Fang Xiao, Shane W. O’Brien, Rashid Gabbasov, (unknown), Ren-Huan Xu, Roshan J. Thapa, Yan Zhou, Émmanuelle Nicolas, Samuel Litwin, Siddharth Balachandran, Luis J. Sigal, Dennis Huszar, Denise C. Connolly	84
17	Lin28b promotes fetal B lymphopoiesis through the transcription factor Arid3a 2015 ·The Journal of Experimental Medicine ·Yan Zhou, Yuesheng Li, Srinivasa Rao Bandi, Lingjuan Tang, Susan A. Shinton, Kyoko Hayakawa, Richard R. Hardy	97
18	Identification of TRIML2, a Novel p53 Target, that Enhances p53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes 2014 ·Molecular Cancer Research ·Che-Pei Kung, Sakina Khaku, Matthew Jennis, Yan Zhou, Maureen E. Murphy	49
19	Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer 2012 ·Clinical Cancer Research ·Shouyu Wang, Xuming Wu, Yansu Chen, Jianbing Zhang, Jingjing Ding, Yan Zhou, Song He, Yongfei Tan, Fulin Qiang, Jin Bai, (unknown), Zhenghua Gong, Aiping Li, Gang Li, Oluf Dimitri Røe, Jianwei Zhou	102
20	Serum lipid/lipoprotein and arterial blood pressure among Chinese nonagenarians/centenarians 2011 ·Blood Pressure ·Yan Zhou, Birong Dong, (unknown), Huang Changquan	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact